PROX1 and neoplasm: Our findings revealed that LV capillaries were predominantly localized at the tumor–stroma border (Figure 1C) and also expressed the bonafide markers VEGF Receptor 3 (VEGFR3) [42] and the PROX1 transcription factor [43] (Figure S1A).